Page last updated: 2024-11-02

pioglitazone and Osteoarthritis of Knee

pioglitazone has been researched along with Osteoarthritis of Knee in 2 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Xue, X1
Dai, T1
Chen, J1
Xu, Y1
Yang, Z1
Huang, J1
Xu, W1
Li, S1
Meng, Q1
Li, Y1
Zhang, Y1
Chen, C1
Zhang, H1
Ma, C1
Xia, Y1

Other Studies

2 other studies available for pioglitazone and Osteoarthritis of Knee

ArticleYear
PPARĪ³ activation suppresses chondrocyte ferroptosis through mitophagy in osteoarthritis.
    Journal of orthopaedic surgery and research, 2023, Aug-24, Volume: 18, Issue:1

    Topics: Animals; Chondrocytes; Ferroptosis; Mitophagy; Osteoarthritis, Knee; Pioglitazone; PPAR gamma; Prote

2023
Establishment of a rabbit model to study the influence of advanced glycation end products accumulation on osteoarthritis and the protective effect of pioglitazone.
    Osteoarthritis and cartilage, 2016, Volume: 24, Issue:2

    Topics: Animals; Cartilage, Articular; Disease Models, Animal; Glycation End Products, Advanced; Hypoglycemi

2016